Is your daily sugar intake too high?
With Régluvits, you can learn to manage it better and with complete peace of mind!
Régluvits contains a patented marine active ingredient, Insea®, which has been widely proven to restore better metabolic health. Insea® is made from brown seaweed, and clinical studies have revealed 3 major health benefits: an improvement in glycaemic health[1], as well as triglyceride levels and waist circumference[2]. The remarkable effects of these algae are added to those of a patented strain of trans-resveratrol produced by natural fermentation, Veri-teTM, a meta-analysis of which demonstrates the positive influence of resveratrol on blood sugar levels in subjects with type 2 diabetes[3]. Finally, a contribution of minerals (chromium & zinc) and B vitamins (B1-B2-B3-B8) combined with a cinnamon extract rich in polyphenols provide natural support for glucose regulation.
Health claims
√ Brown algae such as fucus and ascophyllum help with weight management;
√ Cinnamon and chromium help maintain normal blood sugar levels;
√ Vitamins B1 and B8 contribute to normal energy metabolism;
√ Zinc contributes to normal carbohydrate metabolism.
Advantages of the formula
√ 2 natural & patented active ingredients, extensively documented in randomised double-blind clinical trials: Insea® & Veri-teTM;
√ Cinnamon extract titrated to 20% polyphenols;
√ Zinc in its most assimilable and bioavailable form: bisglycinate;
√ 100% natural & plant-based galenic form (pullulan).
Studies
[1] Paradis ME, Couture P, Lamarche B. A randomised crossover placebo-controlled trial investigating the effect of brown seaweed (Ascophyllum nodosum and Fucus vesiculosus) on postchallenge plasma glucose and insulin levels in men and women. Appl Physiol Nutr Metab. 2011 Dec;36(6):913-9. doi: 10.1139/h11-115. Epub 2011 Nov 16. PMID: 22087795.
[2] Nicolucci A, Rossi MC, Petrelli M. Effectiveness of Ascophyllum nodosum and Fucus vesiculosus on Metabolic Syndrome Components: A Real-World, Observational Study. J Diabetes Res. 2021 Sep 30;2021:3389316. doi: 10.1155/2021/3389316. PMID: 34631894; PMCID: PMC8497120
[3] Zhu, X., Wu, C., Qiu, S. et al, "Effets du resvératrol sur le contrôle du glucose et la sensibilité à l'insuline chez les sujets atteints de diabète de type 2: revue systématique et méta-analyse" Nutr. Metab. (Lond). 14, 60 (2017)
